Department of Dermatology, Paracelsus Medical University Nuremberg, Prof.-Ernst Nathan Straße 1, 90419, Nürnberg, Germany.
Institute of Pathology, Paracelsus Medical University Nuremberg, Prof.-Ernst Nathan Straße 1, 90482, Nuremberg, Germany.
Virchows Arch. 2018 Aug;473(2):241-246. doi: 10.1007/s00428-018-2397-y. Epub 2018 Jun 22.
Multiple familial trichoepitheliomas (MFT) is an autosomal dominantly inherited disease characterized by multiple skin appendage tumors. We describe a patient showing a continuous spectrum of follicular differentiated neoplasms including classical trichoepitheliomas but also infiltrative growing and finally metastasizing malignant follicular differentiated tumors. Germline mutation analysis revealed a nonsense mutation in the cylindromatosis (CYLD) gene. Gene expression analysis by real-time PCR of tumor tissue showed overexpression of glioma-associated oncogene Gli1 mRNA. Treatment with the Hedgehog pathway inhibitor vismodegib resulted in a significant regression of the highly differentiated trichoepitheliomas. Gli upregulation is indicative of an active Hedgehog signaling pathway. We hypothesize that its upregulation is indirectly caused by CYLD mutation which promotes tumor development. Vismodegib treatment could thus provide a new treatment option for patients with this debilitating disorder.
多发性家族性毛发上皮瘤(MFT)是一种常染色体显性遗传疾病,其特征是多发性皮肤附属器肿瘤。我们描述了一位患者表现出连续谱的毛囊分化肿瘤,包括典型的毛发上皮瘤,但也有浸润性生长并最终转移的恶性毛囊分化肿瘤。种系突变分析显示圆柱瘤病(CYLD)基因的无义突变。通过实时 PCR 对肿瘤组织进行基因表达分析显示Gli1 信使 RNA 的过表达。用 Hedgehog 通路抑制剂 vismodegib 治疗可显著消退高度分化的毛发上皮瘤。Gli 的上调表明 Hedgehog 信号通路的激活。我们假设其上调是由 CYLD 突变间接引起的,该突变促进肿瘤的发展。因此,vismodegib 治疗可能为这种衰弱性疾病的患者提供新的治疗选择。